MSH6 mutations in hereditary nonpolyposis colon cancer: Another slice of the pie

Journal of Clinical Oncology

Volumn 22, Issue 22, 2004, Pages 4449-4451

  Offit, Kenneth ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLON CANCER; EDITORIAL; FAMILY HISTORY; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC RISK; HEREDITARY NONPOLYPOSIS COLON CANCER; HUMAN; MISMATCH REPAIR; PRIORITY JOURNAL; BASE MISPAIRING; COLORECTAL TUMOR; DNA REPAIR; GENETICS; NOTE; NUCLEOTIDE SEQUENCE; RISK FACTOR;

DNA BINDING PROTEIN; G T MISMATCH BINDING PROTEIN; G-T MISMATCH-BINDING PROTEIN;

BASE PAIR MISMATCH; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MUTATIONAL ANALYSIS; DNA REPAIR; DNA-BINDING PROTEINS; HUMANS; RISK FACTORS;

EID: 16544373789     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.06.940     Document Type: Editorial

References (17)

1. American Society of Clinical Oncology: American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility. J Clin Oncol 21:2397-2406, 2003
2. Lynch HT, de la Chapelle A: Hereditary colorectal cancer. N Engl J Med 348:919-932, 2003
3. Umar A, Boland C, Terdiman JP, et al: Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261-268, 2004
4. Plaschke J, Engel C, Kruger S, et al: And the German HNPCC-Consortium: Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared to families with MLH1 or MSH2 mutations. J Clin Oncol 22:4486-04494, 2004
5. Offit K, Garber J, Grady M, et al: ASCO Curriculum: Cancer Genetics and Cancer Predisposition Testing (ed 2). Alexandria, VA, American Society of Clinical Oncology, 2004
6. Wijnen J, de Leeuw W, Vasen H, et al: Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet 23:142-144, 1999
7. Peterlongo P, Nafa K, Lerman GS, et al: MSH6 germline mutations are rare in colorectal cancer families. Int J Cancer 107:571-579, 2003
8. Buttin BM, Powell MA, Mutch DG, et al: Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. Am J Hum Genet 74:262-269, 2004
9. Buttin BM, Powell MA, Mutch DG, et al: Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation. Clin Cancer Res 10:481-490, 2004
10. Berends MJ, Wu Y, Sijmons RH, et al: Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis. J Clin Oncol 21:4364-1370, 2003
11. Cederquist K, Emanuelsson M, Goransson I, et al: Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: A population-based study in northern Sweden. Int J Cancer 109:370-376, 2004
12. de la Chapelle A: Microsatellite instability phenotype of tumors: Genotyping or immunohistochemisty? The jury is still out. J Clin Oncol 20:897-899, 2002
13. De Jong AE, Puijenbrock MV, Hendriks Y, et al: Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. Clin Cancer Res 10:972-980, 2004
14. Plaschke J, Kruger S, Dietmaier W, et al: For the German HNPCC Consortium: Eight novel MSH6 germline mutations in patients with familial and nonfamilial colorectal cancer selected by loss of protein expression in tumor tissue. Hum Mutat 23:285, 2004
15. Ribic CM, Sargent DJ, Moore MJ, et al: Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349:247-257, 2003
16. Offit K: Genetic prognostic markers for colorectal cancer. N Engl J Med 342:124-125, 2000
17. GeneTests Web site. http://www.genetests.org